Clinico-histopathologic review of Schnitzler syndrome at Mayo Clinic

Sokumbi O, et al.

J Am Acad Dermatol 67(6):1289-95 · 2012

Grade Bcohorteng

Abstract

Schnitzler syndrome is a rare multisystem disorder, defined by urticaria and monoclonal gammopathy, that is associated with malignancy. Considered a neutrophilic urticarial dermatosis, previous reports have included patients with leukocytoclastic vasculitis. We sought to better define the clinical features, histopathology, and outcomes of Schnitzler syndrome. We retrospectively reviewed clinical records and cutaneous histopathology of all patients with Schnitzler syndrome seen at our institution from January 1, 1972, through July 31, 2011. Of the 20 patients identified, 80% had IgM κ monoclonal gammopathy; others had IgG λ (10%), IgG κ (5%), or IgM κ+λ (5%). Patients had fevers (85%), arthralgias (70%), leukocytosis (70%), increased erythrocyte sedimentation rate (70%), bone pain (50%), lymphadenopathy (40%), and organomegaly (5%); 45% developed a hematologic malignancy. Histopathologic examination (n = 14) showed predominantly neutrophilic perivascular and interstitial inflammation (57%) or predominantly mononuclear cell perivascular inflammation (29%), with eosinophils in 50% of cases. None showed leukocytoclastic vasculitis. Our study was limited by its retrospective design. We added 20 patients to approximately 100 reported cases of Schnitzler syndrome. Neutrophilic urticarial dermatosis was the most common histopathologic pattern, but mononuclear cells were predominant in many cases and the infiltrates often contained eosinophils. A high index of suspicion and careful clinicopathologic correlation are needed to avoid diagnostic delays in this syndrome associated with hematologic malignancy.

Key Findings

  • Comprehensive clinico-histopathologic review
  • Defined neutrophilic urticarial dermatosis pattern

Subject Classification

AdultAgedAged, 80 and overFemaleHospitalsHumansMaleMiddle AgedRetrospective StudiesSchnitzler SyndromeTime Factors

Referenced in (1 disease)

ID: pmid-22627038DOI: 10.1016/j.jaad.2012.04.043PMID: 22627038